Cleveland Biolabs, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 16, 2020 at 08:22 am EST
Cleveland BioLabs, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced operating loss was USD 773,095 compared to USD 518,396 a year ago. Net loss was USD 745,388 compared to USD 449,919 a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.04 a year ago. For the nine months, operating loss was USD 1.809 million compared to USD 2.080 million a year ago. Net loss was USD 1.703 million compared to USD 1.939 million a year ago. Basic loss per share from continuing operations was USD 0.14 compared to USD 0.17 a year ago.